Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019.
Pojsakorn DanpanichkulKanokphong SuparanPriyata DuttaChuthathip KaeosriBanthoon SukphutananYanfang PangNarathorn KulthamrongsriMethasit Jaisa-AadCheng Han NgMargaret TengMasahito NakanoAsahiro MorishitaNaim AlkhouriJu Dong YangVincent L ChenDonghee KimMichael B FallonLuis Antonio DiazJuan Pablo ArabChristos S MantzorosMazen NoureddinJeffrey V LazarusKarn WijarnpreechaPublished in: Metabolism: clinical and experimental (2024)
The burden of MASLD and cardiometabolic conditions is increasing worldwide, with LICs and lower MICs experiencing higher (DALYs) disability per prevalence. As these conditions are preventable, counteracting these trends requires not only the modification of ongoing actions but also the strategizing of immediate interventions.